T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection JM Benito, D Jiménez-Carretero, C Restrepo, JM Ligos, ... International Journal of Molecular Sciences 25 (11), 5937, 2024 | | 2024 |
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study TO Jensen, TA Murray, GA Grandits, MK Jain, B Grund, K Shaw-Saliba, ... The Lancet Microbe, 2024 | | 2024 |
A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection N Rallón, D Jiménez‐Carretero, C Restrepo, JM Ligos, ... Journal of Medical Virology 96 (5), e29646, 2024 | | 2024 |
Monkeypox virus genomic accordion strategies S Monzón, S Varona, A Negredo, S Vidal-Freire, JA Patiño-Galindo, ... Nature Communications 15 (1), 3059, 2024 | | 2024 |
Bacterial nanocellulose spheres coated with meta acrylic copolymer: Vaccinium meridionale swartz extract delivery for colorectal cancer chemoprevention M Osorio, L Posada, E Martínez, V Estrada, G Quintana, ME Maldonado, ... Food Hydrocolloids 147, 109310, 2024 | 4 | 2024 |
Monkeypox virus genomic accordion strategies S Monzon-Fernandez, S Varona Fernandez, A Negredo, S Vidal-Freire, ... | | 2024 |
Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience N Fernández Piñeiro, O Ayerdi Aguirrebengoa, E Orviz García, ... Enfermedades Infecciosas y Microbiologia Clinica, 2024 | | 2024 |
Mpox, herpes, and enteroviruses: Differential diagnosis L Guillén-Calvo, A Negredo, P Sánchez-Mora, P Molero, A Vázquez, ... Wiley, 2024 | | 2024 |
Switching to bictegravir/emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults … D Podzamczer, A Imaz, A Lopez-Lirola, H Knobel, M Masia, C Fanciulli, ... HIV MEDICINE 24, 310-311, 2023 | | 2023 |
Clinical complexity of a cohort of PLWH based on Spanish Gesida/National Policy stratification system I Armenteros, R Homen, A Valls-Carbo, J Vergas, N Cabello-Clotet, ... HIV MEDICINE 24, 578-578, 2023 | | 2023 |
Lasting impact of mpox infection on HIV-1 reservoir and antiviral immune response in people living with HIV G Casado-Fernandez, O de la Calle-Jimenez, L Lemus-Aguilar, I Zarza, ... HIV MEDICINE 24, 691-692, 2023 | | 2023 |
Creation and validation of an imported malaria predictive model including people living with HIV/AIDS (PLWHA) N Cabello-Clotet, F Ortuno, M Fernandez-Lopez, JV San Martin, L Rivas, ... HIV MEDICINE 24, 332-333, 2023 | | 2023 |
2086-DESCRIPTIVO DE CARACTERÍSTICAS SOCIODEMOGRÁFICAS, CLÍNICAS Y CONDUCTUALES DE LOS PACIENTES CON INFECCIÓN POR MPOX EN UN CENTRO DE ITS Y SU HOSPITAL DE REFERENCIA EN MADRID LM Rodríguez-Gallardo, E Orviz, O Ayerdi, M Vera, T Puerta, ... Revista Clínica Española 223, S743-S745, 2023 | | 2023 |
2104-DIAGNÓSTICO CONCOMITANTE DE MPOX Y OTRAS INFECCIONES DE TRANSMISIÓN SEXUAL JB Cuchillo, E Orviz, O Ayerdi, M Vera, JAP García, I Armenteros, ... Revista Clínica Española 223, S235-S236, 2023 | | 2023 |
2065-HÁBITOS DE CONSUMO EN PACIENTES CON DIAGNÓSTICO DE MPOX JB Cuchillo, E Orviz, O Ayerdi, AM Gómez, T Puerta, N Cabello, V Estrada, ... Revista Clínica Española 223, S98-S99, 2023 | | 2023 |
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV … D Podzamczer, A Imaz, A Lopez-Lirola, H Knobel, M Masiá, C Fanciulli, ... Journal of Antimicrobial Chemotherapy 78 (11), 2696-2701, 2023 | 2 | 2023 |
Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2 JR Homen-Fernandez, A Valls, A García, N Cabello, I Ortega, E Orviz, ... Frontiers in Immunology 14, 1267991, 2023 | 1 | 2023 |
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19 N Arber, PL Shah, L Assoumou, C Rokx, N De Castro, A Bakhai, ... Infectious Diseases Now 53 (7), 104760, 2023 | 1 | 2023 |
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events J Martínez-Sanz, J Díaz-Álvarez, M Rosas, R Ron, JA Iribarren, E Bernal, ... EBioMedicine 95, 2023 | 9 | 2023 |
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial LB Ware, N Soleymanlou, DF McAuley, V Estrada, GA Diaz, P Lacamera, ... thorax 78 (8), 816-824, 2023 | 3 | 2023 |